Motif Bio is a clinical stage biopharmaceutical company developing novel antibiotics to treat patients with serious and life-threatening infections caused by multi-drug resistant bacteria.
|Motif Bio to Present Iclaprim Data at Upcoming Scientific Conferences|
September 20, 2018
|Motif Bio Presents Iclaprim Data at ESCMID/ASM Conference|
September 5, 2018
|Motif Bio to Present Iclaprim Data at ESCMID/ASM Conference|
August 17, 2018